CARIS LIFE SCIENCES, INC. Increase (Decrease) in Materials and Supplies
CARIS LIFE SCIENCES, INC. (CAI) reported Increase (Decrease) in Materials and Supplies of $61.64 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInMaterialsAndSupplies · last filed 2026-08-05
- CARIS LIFE SCIENCES, INC. increase (decrease) in materials and supplies for the quarter ending 2026-06-30 was $48.31M, a 931.80% increase year-over-year.
- CARIS LIFE SCIENCES, INC. increase (decrease) in materials and supplies for the quarter ending 2026-03-31 was $13.33M.
- CARIS LIFE SCIENCES, INC. increase (decrease) in materials and supplies for the quarter ending 2025-12-31 was $9.61M.
- CARIS LIFE SCIENCES, INC. increase (decrease) in materials and supplies for the quarter ending 2025-09-30 was $8.52M, a 158.82% increase year-over-year.
- CARIS LIFE SCIENCES, INC. increase (decrease) in materials and supplies for fiscal 2025 was $20.75M.
- CARIS LIFE SCIENCES, INC. increase (decrease) in materials and supplies for fiscal 2024 was -$5.46M, a 223.09% decline from fiscal 2023.
- CARIS LIFE SCIENCES, INC. increase (decrease) in materials and supplies for fiscal 2023 was $4.43M.
| Period end | Increase (Decrease) in Materials and Supplies 3 month | Increase (Decrease) in Materials and Supplies 6 month | Increase (Decrease) in Materials and Supplies 9 month | Increase (Decrease) in Materials and Supplies 12 month |
|---|---|---|---|---|
| 2026-06-30 | $48.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $61.64M 10-Q · filed 2026-08-05 | $71.24M derived: sum of 3 quarters · filed 2026-08-05 | $79.77M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $13.33M 10-Q · filed 2026-05-08 | $22.93M derived: sum of 2 quarters · filed 2026-05-08 | $31.46M derived: sum of 3 quarters · filed 2026-05-08 | $36.14M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $9.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $18.13M derived: sum of 2 quarters · filed 2026-03-03 | $22.81M derived: sum of 3 quarters · filed 2026-08-05 | $20.75M 10-K · filed 2026-03-03 |
| 2025-09-30 | $8.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $13.21M derived: sum of 2 quarters · filed 2026-08-05 | $11.14M 10-Q · filed 2025-11-05 | $9.90M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $4.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.62M 10-Q · filed 2026-08-05 | $1.37M derived: sum of 3 quarters · filed 2026-08-05 | $4.67M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$2.06M 10-Q · filed 2026-05-08 | -$3.31M derived: sum of 2 quarters · filed 2026-05-08 | -$16.00K derived: sum of 3 quarters · filed 2026-05-08 | |
| 2024-12-31 | -$1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $2.04M derived: sum of 2 quarters · filed 2026-03-03 | -$5.46M 10-K · filed 2026-03-03 | |
| 2024-09-30 | $3.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$4.21M 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | -$7.50M 10-Q · filed 2025-08-12 | |||
| 2023-12-31 | $4.43M 10-K · filed 2026-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |